During the past decade, MVZ DermaKiel GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MVZ DermaKiel GmbH" are "Psoriasis" (4 trials) and "Skin Diseases" (1 trials). Many other conditions were trialed in "MVZ DermaKiel GmbH" in a lesser frequency.

Most popular intervention types in "MVZ DermaKiel GmbH" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BMS-986165" (2 trials), "Placebo" (2 trials), "Apremilast" (1 trials), "Guselkumab" (1 trials) and "Orismilast modified release tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "MVZ DermaKiel GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "MVZ DermaKiel GmbH". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MVZ DermaKiel GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MVZ DermaKiel GmbH, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

MVZ DermaKiel GmbH has several departments that took part in Clinical trials: "Tagesklinik DermaKiel" - 2 trials